Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Other financing activities (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Other financing activities for 8 consecutive years, with $97500.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other financing activities changed 0.0% to $97500.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $390000.0, a 6.32% decrease, with the full-year FY2023 number at $446349.0, down 13.01% from a year prior.
  • Other financing activities was $97500.0 for Q3 2025 at KORU Medical Systems, roughly flat from $97500.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $175776.0 in Q1 2023 to a low of $56250.0 in Q1 2021.
  • A 5-year average of $111354.9 and a median of $97500.0 in 2023 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: skyrocketed 153.33% in 2022, then tumbled 38.13% in 2023.
  • KORU Medical Systems' Other financing activities stood at $137707.0 in 2021, then rose by 14.43% to $157576.0 in 2022, then crashed by 38.13% to $97500.0 in 2023, then changed by 0.0% to $97500.0 in 2024, then changed by 0.0% to $97500.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Other financing activities are $97500.0 (Q3 2025), $97500.0 (Q2 2025), and $97500.0 (Q1 2025).